Biogen Inc.
Длинная
Обновлено

Biogen (BIIB) A Roadmap...

220
BIIB came out a nice Gartley Pattern on 4/22.

First stop should be the $277 area as AB=CD, where I would think there will be some profit taking.

Upside targets ($290+) are shown as this evolves into a possible Deep Crab Harmonic Pattern.

Biogen needs FDA drug approval, descent earning against healthy market backdrop for this to happen.


In higher time-frames you may also have a cup and handle formation.

As usual do your own DD

S.
Заметка
An update...
снимок
Заметка
Biogen rallied to our $277+ level and backed off as expected.

It would not surprise me to see some consolidation here and then and run up to the upper D level provided we remain in a healthy broad market

снимок
Заметка
Acting quite well..

снимок

Отказ от ответственности

Информация и публикации не предназначены для предоставления и не являются финансовыми, инвестиционными, торговыми или другими видами советов или рекомендаций, предоставленных или одобренных TradingView. Подробнее читайте в Условиях использования.